International Finance Corporation (IFC), expects to reach a deal for an equity stake with Square Pharmaceuticals Limited (DSE:SQURPHARMA) The Bangladeshi drug maker has disclosed that it rejected an initial proposal by the IFC for some shareholding in the Kenyan plant and instead partnered with Standard Chartered Bank to fund the project through a loan deal. “Of course they (IFC) wanted to have equity, but really we don’t need that,” Square Pharmaceuticals Managing Director Tapan Chowdhury said in an interview, without disclosing the size of stake IFC was looking at.